Company Filing History:
Years Active: 2002
Title: The Innovations of Jeffrey R. Weidner
Introduction
Jeffrey R. Weidner is an accomplished inventor based in Iselin, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that have implications for various diseases. His work is particularly relevant in the context of inflammatory and immune-based diseases.
Latest Patents
Weidner holds a patent for "Chromophore containing compounds and their use in determining interleukin-1β convertase activity." This patent discloses novel chromophore-containing compounds of Formula I and their application in determining interleukin-1β convertase (ICE) activity. ICE has been implicated in a range of diseases affecting the lungs, central nervous system, eyes, joints, cardiovascular system, gastrointestinal system, and skin.
Career Highlights
Jeffrey R. Weidner is associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to contribute to advancements in medical research and therapeutic development.
Collaborations
Weidner has collaborated with notable colleagues, including Kevin Tyler Chapman and Malcolm Maccoss. These collaborations have further enriched his research and innovation efforts.
Conclusion
Jeffrey R. Weidner's contributions to the field of biochemistry through his patented innovations demonstrate his commitment to addressing critical health challenges. His work continues to have a lasting impact on medical research and therapeutic applications.